Skip to content

Clinical trials

Systemic Inflammatory Response Syndrome trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Systemic Inflammatory Response Syndrome Country / region: Belgium Clear all

4 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20131
20181
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1
Cliniques universitaires Saint-Luc- Université Catholique de Louvain1
Mundipharma Research Limited1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sepsis4
Systemic Inflammatory Response Syndrome4
Candidemia2
Candidiasis2
Candidiasis, Invasive2
Fungemia2
Invasive Fungal Infections2
Mycoses2
Pathologic Processes2
Shock, Septic2

Trials

Showing 51 to 4 of 4. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.